SEAMLESS

Chemicals for use in industry and science; biological preparations and biological chemical reagents for use in industry and science; all of the foregoing used for non-medical purposes,

Pharmaceutical and biological preparations and active substances, namely, gene therapies and gene-editing therapies for the treatment of genetic diseases or diseases treatable using gene-editing; medical, pharmaceutical and biopharmaceutical preparations and substances, namely gene and gene editing therapies for the treatment of genetic diseases diseases or diseases treatable using gene-editing; pharmaceutical goods and preparations, namely, gene transfer in the nature of programmable recombinases, regulation in the nature of gene editing, gene modulation and delivery in the nature of gene editing for the treatment of genetic diseases and disorders; products and agents, namely, gene and gene editing therapies for medical and veterinary purposes; genome editable enzymes for medical purposes; DNA recombinant enzymes for medical purposes; DNA editable enzymes, namely, recombinases in the nature of gene editing and integrases in the nature of gene editing; genome editable enzymes for medical purposes for the treatment of diseases; DNA recombinant enzymes for medical purposes for the treatment of diseases; DNA editable enzymes, namely, recombinases in the nature of genome manipulation and integrases in the nature of genome manipulation, for the treatment of diseases.

Scientific and technological services and research, namely, creation in the nature of gene editing and application in the nature of gene therapies of bioinformatic algorithms and models; Science and technology services, namely, scientific and technological research in the field of gene editing technology, scientific development services, technological development in the nature of gene editing technologies and platforms, relating to gene, genome and cell editing and, modulation for the treatment of genetic diseases or diseases treatable using gene-editing, gene modification in the nature of reprogrammable recombinases, engineering in the nature of genome editing, regulation in the nature of genome editing, repair in the nature of gene editing and gene therapy for the development of pharmaceutical and biological preparations or medications for humans and diagnostic goods and services; Consultancy services, relating to the following sectors: Gene, genome and cell editing, modulation, modification, engineering, regulation, repair and therapy for the development of pharmaceutical and biological preparations or medications for humans and diagnostic goods and services; Genome engineering services; Scientific research relating to genetics, Scientific research, relating to genome editing; Scientific analytical laboratory services; Medical research laboratory services; Scientific laboratory services; Biological research laboratory services; Scientific research and development; Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Identification of target sites for genome editing; Identification of target sites for genome editing by means of genome editable enzymes, DNA recombinant enzymes, DNA editable enzymes, in particular recombinases and integrases; Screening processes, namely, in silico screening (bioinformatics and computational approaches) and high-throughput screening (HTS), for the identification of genome editable enzymes, DNA recombinant enzymes, DNA editable enzymes, in particular recombinases and integrases; Research and development for the pharmaceutical industry; Technological consultancy relating to treatment of diseases using DNA editable enzymes, in particular recombinases and integrases.

Medical analysis relating to the treatment of persons; Assay services, for treatment purposes; Medical services, in relation to the following fields: Genome editing; Genetic counseling; Therapy services; Compilation of medical reports; Providing personalised healthcare and medical information, in relation to the field of genome editing; Providing therapy recommendations; Providing of information and counselling services, in relation to the field of genome editing; Therapy consultancy, in relation to the following fields: Genome editing; Counselling relating to recombinases and integrases for the treatment of diseases.